Atlas Trials

First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers

Clinical trial NCT05657782 · UNKNOWN

Trial details

NCT number
NCT05657782
Sponsor
Brigham and Women's Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
CholeraCholera Vaccine Toxicity
Start date
2022-12-12
Primary completion
2024-12-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.